Incucyte® - Live-Cell Analysis Systems’ Post

April is Parkinson’s Awareness Month, and we’d like to recognize all of the hard work and research that has generated a better understanding of the disease and what we can do to treat it. Advancing technologies are helping accelerate the pace at which new therapies are developed, with multiplexed imaging becoming integral to these efforts by revealing the spatial distribution of key proteins in neural tissues. Check out some of this research on Parkinson’s disease and other neurodegenerative disorders: https://lnkd.in/giECekUW Explore the #ABCsofPD from the Parkinson’s Foundation to learn more about the complexity of Parkinson’s disease and recognize its symptoms: https://lnkd.in/gEnv-gX #Parkinsonsdisease #neuroscience #neurodegeneration

🌟 As we approach #SfN2024, we’re excited to showcase our cutting-edge neurological mouse models designed to advance research in neurodegenerative diseases and other neurological disorders. At Cyagen, we offer a diverse range of models that facilitate groundbreaking studies in areas such as Alzheimer's, Parkinson's, and Huntington's diseases. Our models provide researchers with the tools needed to uncover mechanisms of disease and develop innovative therapies. Visit our page to explore how our neurological models can enhance your research: https://lnkd.in/gYD3DCuk Join us at SfN 2024 to learn more about our offerings and discuss how we can support your research initiatives. Let’s make strides in neuroscience together! 💡🔬 #Neuroscience #ResearchInnovation #Cyagen #AnimalModels #SfN2024 #biotechnology #biotech #scienceandtechnology

Microglia, our immune cells in the brain, can engulf various materials, including cellular debris, apoptotic cells, and synaptic proteins.  Impaired synaptic pruning, the process of removing synapses, is abnormal in several conditions, including autism, schizophrenia, and Alzheimer's disease. We can use 3D microscopy to calculate microglia general morphology (indicators of activation and neuroinflammation), but also combine with markers of synaptic proteins, investigating synaptic engulfment by microglia. #FluorescenceMicroscopy #Neuroscience Markers on the video: Microglia: red - Iba1 Synaptic protein: PSD95 cyan, yellow when internalized

Exciting breakthrough: Scientists have created the first 3D brain organoids using cells from multiple human donors, paving the way for personalized medicine and better understanding of brain development. 🔬 Revolutionizing neuroscience with diverse genetic insights 🧠 Simulating broad genetic diversity for accurate predictions 💊 Enhancing drug response predictions for personalized treatments #Neuroscience #PersonalizedMedicine #Innovation 📊 Combining cells from up to five donors for diverse models 📈 Potential to revolutionize drug development and testing 🔍 Detailed study led by Harvard's Paola Arlotta 🧩 Understanding individual brain development variations These 3D model brains with cells from several people are first of their kind https://lnkd.in/gNfms9zu

In vitro brain models are key for developing treatments for neurodegenerative and neuroinflammatory diseases. However, current tools often fall short, extending research timelines. Join Dr. William Bernard of bit.bio and Dr. Martin Engel of Inventia Life Sciences as they present advanced methods for creating scalable 2D and 3D brain co-culture models. Register here: https://lnkd.in/e2mSA2Pz #neuroscience #brainmodels bit.bio Inventia Life Science

🌟 Exciting research alert! A recent study has confirmed the neurodevelopmental role of long non-coding RNA (lncRNA) in humans, revealing its potential influence on conditions such as autism and epilepsy. Learn more here: https://lnkd.in/eFAy75TG At Cyagen, we are dedicated to advancing research in neurodevelopmental disorders with our comprehensive portfolio of humanized mouse models and gene-editing technologies. 😎 Our models can help researchers explore the implications of lncRNA in brain development and its relationship to neurological conditions. 🐭 Check out our services here: https://lnkd.in/gYD3DCuk #Neuroscience #Autism #Epilepsy #Research #Cyagen #biotech #biotechnology Image from GEN Credit: MF3d / E+ / Getty Images

Exciting news to kick off September! I’m thrilled to announce the publication of our latest research titled, "Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer’s Disease: A Systematic Review and Meta-Analysis." This comprehensive study explores the promising intersection of ultrasound technology and Aducanumab in Alzheimer's treatment. Dive into our findings and join the conversation about the future of Alzheimer's therapies. Read more about it https://lnkd.in/gVE9teWd. #AlzheimersResearch #Neuroscience #Innovation #SystematicReview

Are you attending the Fluid & Imaging Biomarkers & Endpoints in Neuroscience Summit in Boston Oct. 22-24? Connect with Matthew Perron from Flywheel to discover how our platform streamlines biomarker data and imaging workflows, supporting groundbreaking neuroscience research. Schedule a meeting today! https://lnkd.in/gwPUF4_3 #Neuroscience #Imaging #MedicalImaging #Biomarkers #ImagingTechnology

Tomorrow it's time for part 2 of our webinar series, this time focussing on single-cell sequencing and organoids! Are you an organoid researcher interested in the power of single-cell sequencing? Join our webinar!

In vitro brain models are key for developing treatments for neurodegenerative and neuroinflammatory diseases. However, current tools often fall short, extending research timelines. Join Dr. Will Bernard of bit.bio and Dr. Martin Engel of Inventia Life Science as they present advanced methods for creating scalable 2D and 3D brain co-culture models. Register here: https://lnkd.in/e2mSA2Pz #neuroscience #brainmodels